R.J. White

2.0k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

R.J. White is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, R.J. White has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in R.J. White's work include Pulmonary Hypertension Research and Treatments (15 papers), Cardiovascular Issues in Pregnancy (4 papers) and Mitochondrial Function and Pathology (3 papers). R.J. White is often cited by papers focused on Pulmonary Hypertension Research and Treatments (15 papers), Cardiovascular Issues in Pregnancy (4 papers) and Mitochondrial Function and Pathology (3 papers). R.J. White collaborates with scholars based in United States, Brazil and Germany. R.J. White's co-authors include Ian J. Reynolds, Lewis J. Rubin, Victor F. Tapson, Karen Miller, Adaani Frost, Raymond L. Benza, Vallerie V. McLaughlin, Julia Harris, Jean‐Luc Vachiéry and Ronald J. Oudiz and has published in prestigious journals such as Journal of Neuroscience, The Journal of Physiology and CHEST Journal.

In The Last Decade

R.J. White

26 papers receiving 1.1k citations

Hit Papers

Mitochondrial Depolarization in Glutamate-Stimulated Neur... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.J. White United States 10 708 577 173 154 124 27 1.2k
Hiroki Yokoo Japan 23 735 1.0× 302 0.5× 109 0.6× 205 1.3× 101 0.8× 56 1.4k
Amit S. Korde United States 11 486 0.7× 105 0.2× 97 0.6× 263 1.7× 60 0.5× 16 814
Gustav Mattiasson Sweden 16 790 1.1× 228 0.4× 32 0.2× 433 2.8× 51 0.4× 20 1.4k
Mutlu Küçük Türkiye 20 266 0.4× 207 0.4× 45 0.3× 152 1.0× 51 0.4× 51 1.1k
Qazi M. Ashraf United States 19 570 0.8× 166 0.3× 143 0.8× 238 1.5× 19 0.2× 52 1.0k
Sylvia F. Chen United States 14 741 1.0× 416 0.7× 57 0.3× 223 1.4× 19 0.2× 16 1.5k
Katsuyoshi Shimizu Japan 15 271 0.4× 259 0.4× 87 0.5× 159 1.0× 46 0.4× 46 929
Daniel Abran Canada 25 388 0.5× 120 0.2× 157 0.9× 407 2.6× 125 1.0× 38 1.4k
José Melena United Kingdom 19 1.1k 1.5× 364 0.6× 29 0.2× 144 0.9× 26 0.2× 30 1.8k

Countries citing papers authored by R.J. White

Since Specialization
Citations

This map shows the geographic impact of R.J. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.J. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.J. White more than expected).

Fields of papers citing papers by R.J. White

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.J. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.J. White. The network helps show where R.J. White may publish in the future.

Co-authorship network of co-authors of R.J. White

This figure shows the co-authorship network connecting the top 25 collaborators of R.J. White. A scholar is included among the top collaborators of R.J. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.J. White. R.J. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
White, R.J., et al.. (2021). An untapped resource: characteristics of thrombus recovered from intermediate or high risk pulmonary embolus patients. Cardiovascular Pathology. 57. 107392–107392. 3 indexed citations
3.
White, R.J., et al.. (2021). Vasodilator use in precapillary pulmonary hypertension with end stage kidney disease: A single center experience. Respiratory Medicine. 188. 106596–106596. 4 indexed citations
5.
Tapson, Victor F., Tomás Pulido, Pablo Sepúlveda, et al.. (2019). Treatment with Oral Treprostinil Delays Time to Clinical Worsening in Patients with Pulmonary Arterial Hypertension - Results from FREEDOM-EV. The Journal of Heart and Lung Transplantation. 38(4). S94–S95. 9 indexed citations
6.
7.
Hoeper, Marius M., Hossein Ardeschir Ghofrani, Raymond L. Benza, et al.. (2017). REPLACE: A prospective, randomized trial of riociguat replacing phosphodiesterase 5 inhibitor therapy in patients with pulmonary arterial hypertension who are not at treatment goal. PA2417–PA2417. 4 indexed citations
9.
Hoeper, Marius M., Vallerie V. McLaughlin, Joan Albert Barberà, et al.. (2016). Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study. The Lancet Respiratory Medicine. 4(11). 894–901. 49 indexed citations
10.
White, R.J., et al.. (2013). Subcutaneous Treprostinil is Well Tolerated with Infrequent Site Changes and Analgesics. Pulmonary Circulation. 3(3). 611–621. 25 indexed citations
11.
Bourge, Robert C., Victor F. Tapson, Zeenat Safdar, et al.. (2012). Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension. Cardiovascular Therapeutics. 31(1). 38–44. 29 indexed citations
12.
White, R.J., et al.. (2011). Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension. Expert Opinion on Pharmacotherapy. 12(16). 2583–2593. 8 indexed citations
13.
White, R.J.. (2009). Update on the Development of Oral Prostacyclin Analogs for the Treatment of PAH. Advances in Pulmonary Hypertension. 8(1). 32–36. 3 indexed citations
14.
White, R.J.. (2004). Pulmonary arterial hypertension: building a better mouse trap for 2010. Drug Discovery Today Therapeutic Strategies. 1(3). 351–359. 2 indexed citations
15.
16.
White, R.J. & Ian J. Reynolds. (1997). Mitochondria accumulate Ca2+ following intense glutamate stimulation of cultured rat forebrain neurones.. The Journal of Physiology. 498(1). 31–47. 170 indexed citations
17.
White, R.J. & Ian J. Reynolds. (1996). Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure. Journal of Neuroscience. 16(18). 5688–5697. 516 indexed citations breakdown →
18.
White, R.J. & Ian J. Reynolds. (1995). Mitochondria and Na+/Ca2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons. Journal of Neuroscience. 15(2). 1318–1328. 251 indexed citations
19.
Neville, William E., et al.. (1964). RELATIONSHIP OF FLOW RATE, "EXCESS LACTATE," AND BUFFER BASE DURING CLOSED CHEST PROFOUND HYPOTHERMIC PERFUSION WITH A PUMP OXYGENATOR.. PubMed. 55. 281–90. 5 indexed citations
20.
White, R.J. & DE Donald. (1960). Total cerebral ischemia and perfusion hypothermia in the dog.. PubMed. 11. 410–1. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026